Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04131543
Title Phase II Study With Cabozantinib in Patients With RET Positive NSCLC (CRETA)
Acronym CRETA
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Bologna
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA

Additional content available in CKB BOOST